#PrognosticScore - Twitter Hashtag

10 months ago

A New #PrognosticScore Based on #CellMediated Immunity for #Cytomegalovirus Infection After #Transplantation #VisualAbstract by @NephroSeeker https://t.co/euVaUQiyrF

KIReports's tweet photo. A New #PrognosticScore Based on #CellMediated Immunity for #Cytomegalovirus Infection After #Transplantation

#VisualAbstract by @NephroSeeker

https://t.co/euVaUQiyrF https://t.co/JDreezKTA0

1

13

5

4

1K

Nature Medicine

@NatureMedicine

about 3 years ago

A large, publicly available dataset integrating RNA, whole-exome, T cell receptor and 16S rRNA sequencing from patients with #ColonCancer enables the discovery of a #PrognosticScore consisting of tumor, immune and microbial features. #Microbiome #Tcell https://t.co/wAFGqIs1Mr

NatureMedicine's tweet photo. A large, publicly available dataset integrating RNA, whole-exome, T cell receptor and 16S rRNA sequencing from patients with #ColonCancer enables the discovery of a #PrognosticScore consisting of tumor, immune and microbial features. #Microbiome #Tcell https://t.co/wAFGqIs1Mr https://t.co/Ffx45bquWd

1

112

43

23

39K

Nature Medicine

@NatureMedicine

about 3 years ago

A large, publicly available dataset integrating RNA, whole-exome, T cell receptor and 16S rRNA sequencing from patients with #ColonCancer enables the discovery of a #PrognosticScore consisting of tumor, immune and microbial features. #Microbiome #Tcell https://t.co/wAFGqIs1Mr

0

161

53

25

31K

Melissa Bersanelli @Bersa_Dr_Mel

over 3 years ago · Noceto

Finally published #RCC #EAP #IpiNivo #kidneycancer #druginteractions #prognosticscore #italianresearch #clinicalresearch @marcodoc @procopio_g @GFornarini @CamilloPorta @MasiniCristina @DrIacovelli

Bersa_Dr_Mel's tweet photo. Finally published #RCC #EAP #IpiNivo #kidneycancer #druginteractions #prognosticscore #italianresearch #clinicalresearch @marcodoc @procopio_g @GFornarini @CamilloPorta @MasiniCristina @DrIacovelli https://t.co/9dxCQNI2Ai

1

8

0

Inst. Carnot CALYM @CarnotCALYM

over 6 years ago

[ARTICLE] @BloodJournal« High TMTV at baseline allows discrimination of survival even in patients aged 60 to 80 years responding to R-CHOP. » #PrognosticScore #UltrariskDLBCL by @LysaLymphoma & @CarnotCALYM members 👏 https://t.co/7vn8teWdPO